TrialBlood2013

Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.

Corey Cutler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.